However, clinical trials using hormone replacement therapy (HRT) and selective estrogen receptor modulators (SERM) to mimic the neuronal protective activity of estrogen in AD patients were unsuccessful and were abandoned due to the side effects. The gene discussed is ESR1; the disease is Alzheimer disease.